Victoria Elliot1, Thomas Cairns, H Terence Cook. Show Affiliations » 1. Department of Histopathology, Imperial College, Hammersmith Hospital, London, UK.
Abstract
Entities: Disease Species
Mesh： See more » AdolescentAngiotensin II Type 1 Receptor Blockers/therapeutic useAngiotensin-Converting Enzyme Inhibitors/therapeutic useAtorvastatinBiopsy, NeedleDisease ProgressionFollow-Up StudiesHematuria/etiologyHeptanoic Acids/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHyperlipidemias/drug therapyHyperlipidemias/etiologyImmunoglobulin A/analysisImmunoglobulin M/analysisImmunosuppressive Agents/therapeutic useKidney Glomerulus/ultrastructureLupus Erythematosus, Systemic/complicationsLupus Erythematosus, Systemic/diagnosisLupus Erythematosus, Systemic/drug therapyLupus Nephritis/classificationLupus Nephritis/drug therapyLupus Nephritis/pathologyLupus Nephritis/therapyMaleOrganelles/ultrastructurePlasma ExchangePyrroles/therapeutic useSclerosisSeverity of Illness IndexSoftware Design
Substances： See more » Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsHeptanoic AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsImmunoglobulin AImmunoglobulin MImmunosuppressive AgentsPyrrolesAtorvastatin
Year: 2006 PMID： 16377401 DOI： 10.1053/j.ajkd.2005.06.027
Source DB: PubMed Journal: Am J Kidney Dis ISSN： 0272-6386 Impact factor: 8.860